Skip to content

Clinical trials

Phase 3 Lung Diseases trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 3 Country / region: Italy Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20101
20122
20131
20142
20161
20171
20181
20194
20201
20221
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting5
Terminated5
Active, not recruiting2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
United Therapeutics3
Novartis Pharmaceuticals2
Aeris Therapeutics1
Bayer1
Daiichi Sankyo1
Eli Lilly and Company1
GlaxoSmithKline1
Hoffmann-La Roche1
InterMune1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases23
Respiratory Tract Diseases11
Carcinoma, Non-Small-Cell Lung7
Lung Neoplasms6
Bronchial Diseases5
Pulmonary Disease, Chronic Obstructive5
Neoplasms4
Respiratory Tract Neoplasms4
Thoracic Neoplasms4
Asthma3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.